SC
IMPV

Scotia Capital’s Imperva, Inc. IMPV Stock Holding History

Scotia Capital’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,000
Closed -$289K – 623
2013
Q4 		$289K Buy
+6,000
New +$252K 0.01% 459
2013
Q3 		– Sell
-4,560
Closed -$205K – 530
2013
Q2 		$205K Buy
+4,560
New +$179K 0.01% 429

Other funds holding IMPV

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Scotia Capital's IMPV Position: Q1 2014 in Review

Scotia Capital sold out of Imperva, Inc. (IMPV) in Q1 2014, closing a stake of 6,000 shares — an estimated $289K sold.

Scotia Capital first reported a position in IMPV in Q2 2013 and held it in 2 quarters. The position peaked at $289K in Q4 2013. 130 funds tracked by Wall St. Rank hold IMPV as of Q1 2014.

  • Scotia Capital reported no remaining Imperva, Inc. position as of Q1 2014 after selling out during the quarter.
  • Scotia Capital sold 6,000 Imperva, Inc. shares in Q1 2014, an estimated $289K.
  • Scotia Capital first reported a position in Imperva, Inc. in Q2 2013 and held it in 2 quarters.
  • Scotia Capital's Imperva, Inc. position peaked at $289K in Q4 2013.
  • 130 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2014.

Based on Scotia Capital's 13F filing for Q1 2014, filed 14 May 2014.